REVIEW   

Minerva Respiratory Medicine 2023 June;62(2):83-8

DOI: 10.23736/S2784-8477.21.01940-4

Copyright © 2021 EDIZIONI MINERVA MEDICA

language: English

An overview on the role of antibiotic therapy in the treatment of Coronavirus disease 2019 (COVID-19)

Zeinab MOHSENI AFSHAR ¹, Babak SAYAD ¹, Alireza JANBAKHSH ¹, Soheil EBRAHIMPOUR ², Arefeh BABAZADEH ² ✉

¹ Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran; ² Infectious Diseases and Tropical Medicine Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran

The coronavirus disease 2019 (COVID-19) pandemic made daily news of deaths. According to several studies, a significant number of deaths due to COVID-19 resulted from secondary bacterial infections. Consequently, antimicrobials are important tools in helping to defend against mortality in patients with COVOD-19. It should be noted that, antimicrobial resistance (AMR) is now estimated to cause notable global deaths. Points to consider that proportion of COVID-19 cases that are prescribed antibiotics are unclear and may be associated with patient injury and AMR. Thus, the aim of the current review was to focus on the role of antibiotic therapy in the treating of COVID-19.

KEY WORDS: COVID-19; Anti-bacterial agents; Therapeutics; SARS-CoV-2